Polyoxidonium tablets 12 mg 10 pieces.

Manufacturer

NGOs Petrovax Farm, Russia

Composition

Active substance:

Azoximer bromide – 12 mg;

Excipients:

mannitol – 3.6 mg,

Povidone K 17 – 2.4 mg,

lactose monohydrate – 185.0 mg,

potato starch – 45.0 mg,

Stearic Acid – 2.0 mg.

Indications

in adults and adolescents over 12 years for the treatment and prevention of infectious and inflammatory diseases (viral, bacterial and fungal etiologies) are not amenable to standard therapy in the acute phase and in remission.

In the treatment of:

• recurrent acute and chronic infectious and inflammatory diseases of the oropharynx, sinus, upper respiratory tract, the inner and middle ear;
• allergic disease complicated by recurrent bacterial, fungal and viral infections (including hay fever, bronchial asthma);
• Rehabilitation frequent and long (more than 4-5 times per year) ill persons.

In monotherapy:

• for the prevention of recurrent herpes infection;
• for prevention of exacerbations of chronic seasonal outbreaks oropharyngeal infections, paranasal sinuses, upper respiratory tract, the inner and middle ear;
• in immunocompromised individuals for the prevention of influenza and other acute respiratory infections in the pre-epidemic period;
• for correction of secondary immunodeficiencies resulting from aging or exposure to adverse factors.

Contraindications

• Increased individual sensitivity;
• pregnancy, breast-feeding;
• Children under 3 years;
• acute renal failure;
• rare hereditary intolerance to lactose, lactase deficiency, glucose-galaktoznoymalabsorbtsii syndrome.

Carefully

If you have a disease, referred to in this section, contact your doctor before taking the drug:

– Chronic renal failure (use no more than 2 times per week).

Side effects

Side effects were recorded.

If you notice any side effects not listed in the instructions, tell your doctor.

How to accept, acceptance rate and dosage

Use according to the drug only indications that the application and in those doses which are specified in the instruction.

If after treatment there is no improvement or symptoms are aggravated, or there are new symptoms, you should consult with your doctor.

Orally and sublingually for 20-30 minutes before meals daily, 2 times a day: children older than 10 years and adults – 1 tablet, children from 3 to 10 years – ½ tablets (6 mg).

If necessary, may conduct repeated courses of therapy in 3-4 months. When the re-appointment of the drug efficacy is not reduced.

The recommended treatment regimen

sublingually

For the treatment of adults:

• influenza and acute respiratory infections – 1 tablet 2 times daily for 7 days;
• inflammation of the oropharynx – 1 tablet 2 times a denv within 10 days;


• exacerbations of chronic respiratory diseases, paranasal sinuses, chronic otitis – 1 tablet 2 times a day for 10 days;
• allergies (including hay fever, bronchial asthma), complicated by recurrent bacterial, fungal and viral infektsiey- 1 tablet 2 times a day for 10 days.

For the treatment of children 3 to 10 years:

• influenza and acute respiratory infections – ½ tablet 2 times daily for 7 days;
• inflammation of the oropharynx – at ½ tablet 2 times a day for 7 days;


• allergic disorders (including hay fever, asthma), complicated by recurrent bacterial, fungal and viral infections – ½ tablet 2 times daily for 7 days

.

For the treatment of children over 10 years:

• influenza and acute respiratory infections – 1 tablet 2 times daily for 7 days;
• inflammation of the oropharynx – 1 tablet 2 times a day for 7 days;

• exacerbations of chronic respiratory diseases, paranasal sinuses, chronic otitis – 1 tablet 2 times a day for 7 days;
• allergic disorders (including hay fever, asthma), complicated by recurrent bacterial, fungal and viral infections – 1 tablet 2 times daily for 7 days

.

For the prevention of adult:

• influenza and acute respiratory infections in the pre-epidemic period – 1 tablet per day for 10 days;

• recurrent herpetic infection and nasal labial – 1 tablet 2 times a day for 10 days;
• exacerbations of chronic foci of infection of the oropharynx, paranasal sinuses, upper respiratory tract, middle and inner ear – 1 tablet once a day for 10 days;


• secondary immunodeficiencies resulting from aging or exposure to adverse factors – 1 tablet 1 time a day for 10 days

.

For the prevention of children from 3 to 10 years:

• influenza and acute respiratory infections in the pre-epidemic period – at ½ tablet per day for 7 days;

• recurrent herpetic infection and nasal labial – at ½ tablet 2 times daily for 7 days;
• exacerbations of chronic foci of infection of the oropharynx, paranasal sinuses, upper respiratory tract, middle and inner ear – at ½ tablet once a day for 10 days

.

For the prevention of children over 10 years:

• influenza and acute respiratory infections in the pre-epidemic period – 1 tablet per day for 7 days;

• recurrent herpetic infection and nasal labial – 1 tablet 2 times daily for 7 days;
• exacerbations of chronic foci of infection of the oropharynx, paranasal sinuses, upper respiratory tract, the middle ear and the inner 1 tablet once a day for 10 days.

orally

For the treatment of adults:

• diseases of the upper and lower respiratory tract infections – 1 tablet with 2 times 10 days

.

For the treatment of children over 10 years:

• diseases of the upper and lower respiratory tract infections – 1 tablet with 2 times 10 days

Storage conditions

At a temperature of 2 to 25 ° C.

Keep out of the reach of children.

Active substance

Azoximer bromide

Interaction

Azoximer bromide does not inhibit isozymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, cytochrome P-450, and the drug is compatible with antibiotics, antiviral, antifungal and antihistamines, glucocorticosteroids and cytostatics.

If you accept the above or any other medicines (including OTC), before taking polioksidoniya consult your doctor.

Special conditions

With the development of allergic reactions should stop using Polioksidoniy® drug and consult a doctor.

If necessary, discontinuation Polioksidoniy® cancellation can be done immediately without gradual dose reduction.

In the case of missing the next dose administration subsequent its application should be performed in the normal mode, as indicated in the instructions or recommended by a doctor. The patient should not double the dose administered to compensate for missed doses.

Do not use the drug if there is visual evidence of his unfitness (stacking fault discoloration tablets).

Effects on ability to drive vehicles and other mechanisms

Use of the drug Polioksidoniy® does not affect the ability to perform potentially hazardous activities that require high concentration and speed of psychomotor reactions (including means of transport management, work with moving machinery).

Pregnancy and lactation

Polyoxidonium is contraindicated in pregnancy, breast-feeding and children up to 6 months (no clinical experience).

Overdose

Cases of overdose are not logged in.